Importantly, B7H3 is highly expressed in tumor-infiltrating blood vessels but not pathological angiogenesis, and thus, has higher specificity; this can facilitate specific tumor therapy since vascular endothelial growth factor therapy cannot distinguish pathological and physiological angiogenesis [18]. The gene discussed is VEGFA; the disease is neoplasm.